PubRank

Daniel P Hart

Author PubWeight™ 11.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses. Blood 2003 1.70
2 Monoclonal T-cell receptors: new reagents for cancer therapy. Mol Ther 2007 1.34
3 Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization. Br J Haematol 2012 1.17
4 Targeting the Wilms tumor antigen 1 by TCR gene transfer: TCR variants improve tetramer binding but not the function of gene modified human T cells. J Immunol 2007 1.15
5 Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID mice. Haematologica 2009 1.00
6 Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A. Blood 2013 0.96
7 WT1-specific T cell receptor gene therapy: improving TCR function in transduced T cells. Blood Cells Mol Dis 2007 0.85
8 T-cell receptor gene therapy for cancer: the progress to date and future objectives. Expert Opin Biol Ther 2007 0.82
9 Pre-analytical heat treatment and a FVIII ELISA improve Factor VIII antibody detection in acquired haemophilia A. Br J Haematol 2014 0.78
10 A large-scale computational study of inhibitor risk in non-severe haemophilia A. Br J Haematol 2014 0.77
11 Inhibitors in nonsevere haemophilia A: outcome and eradication strategies. Thromb Haemost 2015 0.76
12 The incidence and treatment of bleeding episodes in non-severe haemophilia A patients with inhibitors. Thromb Haemost 2015 0.75